Discussion on problems of prostate cancer treatment and the role of cabazitaxel in treatment of patients with metastatic castration-resistant prostate cancer: Decision of the Expert Board
- Authors: , , , , , , , , , , , , , , ,
- Issue: Vol 13, No 1 (2017)
- Pages: 157-160
- Section: RESOLUTION
- Published: 30.03.2017
- URL: https://oncourology.abvpress.ru/oncur/article/view/671
- ID: 671
Cite item
Full Text
Abstract
About the authors
Author for correspondence.
д.м.н. Russian Federation
д.м.н. Russian Federation
д.м.н. Russian Federation
д.м.н. Russian Federation
д.м.н. Russian Federation
д.м.н. Russian Federation
д.м.н. Russian Federation
к.м.н. Russian Federation
д.м.н. Russian Federation
к.м.н. Russian Federation
д.м.н. Russian Federation
д.м.н. Russian Federation
д.м.н. Russian Federation
к.м.н. Russian Federation
д.м.н. Russian Federation
к.м.н. Russian Federation
References
Supplementary files

